APPROVAL??The AcuVidCOVID Antigen Test has received conditional approval for in home testing in the United States, certified under the Clinical Testing Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform high, moderate or waived complexity tests. The AcuVidCOVID Antigen Test is authorized for use for at home testing; Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Specimens should be collected with appropriate infection control precautions. Current guidance for COVID-19 infection control precautions is available at the CDCs website (see links provided in Where can I go for updates and more information? section). Use appropriate personal protective equipment when collecting and handling specimensfromindividualssuspected of having COVID-19 as outlined in the CDC Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19). For additional information, refer to CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation https://todaybiznews.com/finance/market/thank-you-sportsman-for-fact-sheet-on-acuvid-for-tsxvthrm-by-isnarain/